Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0288 per EA under NDC 70010020309. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Jan 8, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010020309
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078403FDA Approved
1/8/2008
TE Code
AB
On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 170 times since Jul 5, 2023, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0288 per EA |
|---|---|
| All-time high | $0.0417 (Jul 12, 2023) |
| All-time low | $0.0282 (Aug 19, 2026) |
| 52-week high | $0.0336 |
| 52-week low | $0.0282 |
| Median price | $0.0324 |
| Average price | $0.0331 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sertraline hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0288 per EA (NDC 70010020309), effective Sep 30, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 30.9%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Jul 5, 2023, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0282 (Aug 19, 2026) to a high of $0.0417 (Jul 12, 2023), with a median of $0.0324 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SERTRALINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 70010020309) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.